Thursday - February 5, 2026
GSK Delivers Strong 2025 Performance and Re-Affirms Long-Term Outlooks
February 05, 2026
LONDON, England, Feb. 5 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release:

* * *

GSK delivers strong 2025 performance and re-affirms long-term outlooks

Sales, profit and earnings growth driven by strong Specialty Medicines performance

* Total 2025 sales pound sterling32.7 billion +4% AER; +7% CER

* Specialty Medicines sales pound sterling13.5 billion (+17%); Respiratory, Immunology &a . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products